Select Bibliography

Filter by any of these (after searching):

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 4 items

Psychometric Testing of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization (CI-PeriNomS) and Alliance for Clinical Trials in Oncology (Alliance) A151408 Study Data

Lavoie Smith, Ellen M. , Banerjee, Tanima , Yang, James J. ... - - Cancer Nurs - 2019

Manuscript - Primary - Primary - Symptom Inter - A151408

Development of a Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma (Alliance)

Luan, Danny , Chen, Zhengming , Jakobsen, Lasse , Maurer, Matthew ... - ASH - Blood - 2022

Abstract - Primary - Primary - Lymphoma - A152112 , CALGB-50303 , E1412 , E4494 , S1001

The reliability, validity, and sensitivity of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-chemotherapy-induced Peripheral Neuropathy (QLQ-CIPN-20).

Smith, E. M. L. , Yang , J. , Banerjee, T. , Loprinizi, C. ... - MNRS - - 2016

Abstract - Primary - Primary - Symptom Inter - A151408 , N06CA , CI-PeriNomS , N08C1 , N08CA , N08CB

Is local review of positron emission tomography scans sufficient in diffuse large B-cell lymphoma clinical trials? A CALGB 50303 analysis.

Torka, Pallawi , Pederson, Levi D , Knopp, Michael V , Poon, David ... - - Cancer Med - 2023

Manuscript - Secondary-not-in-original - Primary - Lymphoma - CALGB-50303